An innovation launched this company

Little Green Pharma was founded in 2016 with the aims of improving the quality of life for a child debilitated by seizures using the company’s patented small-particle formulation and to take advantage of opportunities in the emerging medicinal cannabis industry in Australia and overseas.

Since then, the company has invested significantly into product development, sales and marketing and cultivation capabilities with the aim of becoming a leading Australian and Global medicinal cannabis company and achieved the following milestones:

April 2017

License to cultivate and produce Medicinal Cannabis granted by the Federal Office of Drug Control (ODC) in Australia

December 2017

LGP’s first crop of Medicinal Cannabis started cultivation in Western Australia

March 2018

LGP granted a patent for its small particle liposomal delivery system

April 2018

Australia’s first crop of Medicinal Cannabis for commercial use harvested

August 2018

First Australian-grown cannabis medicines available to Australian patients

January 2019

Export License granted by the Federal Department of Health


Signed agreements with organisations in Germany, Canada and NZ

October 2020

Little Green Pharma granted Therapeutic Goods Administration (TGA) Good Manufacturing Practices (GMP) licence

November 2020

First Australian Medicinal Cannabis Oil Exported to Germany

January 2021

LGP appointed as a primary medicinal cannabis oil manufacturer for national French medicinal cannabis

June 2021

LGP acquires world-class, fully operational GACP cultivation and GMP licensed medicinal cannabis asset in Denmark (EU)

September 2021

LGP granted Schedule 9 licence to supply psilocybin by WA Government Department of Health (beginnings of psychedelics separate unlisted entity, Reset Mind Sciences Ltd)

November 2021

LGP secures first registration for locally produced cannabis medicine In Denmark.

January 2022

LGP signs four-year agreement with PharmaServe for the distribution of LGP-branded oil medicines and cannabis flower in Greece.

February 2022

LGP awarded Government tender for medicinal cannabis flower from its Danish Facility into Italy.

April 2022

LGP signs three-year sales agreement with Deutsche Medizinalcannabis GmbH (Demecan), one of Germany’s largest cannabis distributors.

May 2022

LGP enters into a medicinal cannabis distribution agreement with Sana Life Sciences Ltd for the supply of LGP branded products for distribution in the United Kingdom and UK crown dependences.

Return to Top